Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Kallyope digests $112m in series C round
Illumina was among the returning investors for the round that will help Columbia spinout Kallyope prepare a weight loss treatment for clinical trials.
CureFit cuts to $109m round
Temasek led a funding round that expanded the UC-RNT Fund-backed health and wellness services platform's overall financing to approximately $390m.
Lilium reaches higher altitude with $240m
The urban airborne vehicle spinout of TU Munich closed more than $240m in funding, in a Tencent-led round reportedly valuing it at up to $1bn.
Nurix nabs $120m
UC Berkeley's Nurix Therapeutics will use the capital to prepare two protein modulation-based immuno-oncology drugs for the clinic.
Big deal: Element Science factors in $145m series C
Uday Kumar, whose previous spinout iRhythm is trading with a market cap of $2.6bn, has collected $145.6m in a GV-backed round for his latest venture.
GV helps pump series C funding into Element
The wearable defibrillator developer, founded by Stanford adjunct professor Uday Kumar, has raised more than $145m that will support the launch of its lead product.
Novartis helps plant $100m in Pliant
Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.
Immunocore imports $130m in series B round
Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.

Other News

SambaNova processes $250m series C
GV and Intel Capital returned to reinvest in the computing technology provider, which was co-founded by Stanford professors and has now raised more than $450m altogether.
Graphcore grows series D to $350m
Graphcore, which traces its origins back to University of Bristol, has added $150m to a round that already included Ahren Innovation Capital.
Verana charts course to $100m
Oak Ridge spinout Verana Health has completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.
Skylo escapes stealth with $116m
SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.
Inscripta cribs $125m in series D round
CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.
CureFit starts training for $100m round
Temasek could reportedly invest in CureFit at a valuation of $800m, three years after UC-RNT Fund supplied $25m to the wellness services provider.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
test reg